Aug. 2 at 1:02 PM
$XERS "We're going to do an R&D day in early fall and be able to walk through all the ins and outs that everybody wants to know, specifically around not only the market opportunity, but the work we're doing on the device and formulation, and then finally, the phase III trial." -John Shannon
So maybe we finally get details in say October and trials start in Dec or Jan. Hopefully they announce a firm date during the earnings this week or very shortly after. They might want it to be a separate announcement to create as much buzz as possible.
If trial costs drag through the entirety of 2028 we may have to wait for 2029 for the stock to really run. Will just really depend on how fast they can grow revenue and EPS.
I think we should finally see
$20 plus in 2028 either way though. Then maybe
$30-
$40 in 2029. We will be there soon enough to find out.
